Helixmith Co., Ltd (KOSDAQ:084990)
9,090.00
+310.00 (3.53%)
Apr 10, 2026, 3:30 PM KST
Helixmith Revenue
In the year 2025, Helixmith had annual revenue of 2.60B KRW, down -47.77%. Helixmith had revenue of 490.24M in the quarter ending December 31, 2025, a decrease of -69.98%.
Revenue
2.60B
Revenue Growth
-47.77%
P/S Ratio
161.10
Revenue / Employee
68.37M
Employees
38
Market Cap
418.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.60B | -2.38B | -47.77% |
| Dec 31, 2024 | 4.97B | 772.35M | 18.38% |
| Dec 31, 2023 | 4.20B | 1.40B | 50.08% |
| Dec 31, 2022 | 2.80B | 483.36M | 20.87% |
| Dec 31, 2021 | 2.32B | -1.93B | -45.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Cross Holdings | 2.45T |
| Bioneer | 330.11B |
| Medy-Tox | 247.29B |
| BINEX | 168.47B |
| GC Cell | 165.52B |
| JETEMA, | 76.90B |
| HLB Therapeutics | 69.56B |
| SillaJen | 9.23B |
Helixmith News
- 5 months ago - A Look Into Vipshop Holdings Inc's Price Over Earnings - Benzinga
- 1 year ago - P/E Ratio Insights for Vipshop Holdings - Benzinga
- 1 year ago - Price Over Earnings Overview: Vipshop Holdings - Benzinga